Capricor Therapeutics, Inc. · 1 month ago
Director of Program Strategy & Management
Capricor Therapeutics is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. The Director of Program Strategy & Management will lead the full lifecycle of strategic programs across the therapeutic portfolio, overseeing cross-functional initiatives and ensuring alignment with corporate goals and compliance standards.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Lead strategic programs from concept through completion, ensuring alignment with business objectives
Manage cross-functional teams across R&D, regulatory, operations, and quality to deliver program milestones
Develop and maintain integrated program plans, tracking deliverables, timelines, risks, and budgets
Identify and mitigate program-level risks through proactive planning and stakeholder engagement
Provide regular updates to senior leadership, including dashboards, risk assessments, and decision support
Implement and refine program management processes and tools to drive operational excellence
Ensure all program activities meet regulatory requirements and internal quality standards
Mentor and guide team members and stakeholders to foster collaboration and accountability
Support strategic planning and scenario modeling for future growth initiatives
Qualification
Required
Bachelor's degree in a relevant field
10+ years of program management experience in biopharma, cell therapy, or biotech
Proven leadership in managing cross-functional teams and influencing stakeholders
Strong strategic thinking with the ability to translate vision into actionable plans
Excellent communication skills for engaging with technical and executive audiences
Proficiency in program management tools (e.g., Smartsheet, MS Project, Jira) and Microsoft Office Suite
Deep understanding of FDA and EMA regulatory frameworks
Strong analytical and problem-solving skills with a focus on continuous improvement
Preferred
advanced degree (MBA, MS, PhD)
Company
Capricor Therapeutics, Inc.
Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives.
Funding
Current Stage
Public CompanyTotal Funding
$329.5MKey Investors
Nippon ShinyakuNational Institutes of HealthCalifornia Institute for Regenerative Medicine
2025-12-05Post Ipo Equity· $150M
2024-10-17Post Ipo Equity· $75M
2024-09-17Post Ipo Equity· $15M
Recent News
MarketScreener
2025-12-17
Genetic Engineering News
2025-12-09
Company data provided by crunchbase